drugset / Trial / NCT00989937
Oxytocin Add-on Study for Stable Anxiety Patients
RandomizedCrossoverTriple-blindTreatment
Summary
The objective of the study is to compare the efficacy of intranasal oxytocin versus intranasal placebo to improve anxiety symptoms in patients with a variety of anxiety disorders.
Timeline
- Start
- 2009-02
- Primary completion
- 2011-04
- Completion
- 2011-04
Outcome
Outcome not reported
Stopped (Business): “Break in funding”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxytocin | Peptide | 40 iu | Intranasal |